Technology-led oncology platform providing end-to-end cancer care: prevention, early detection (e.g. HPV screening), diagnostics, treatment and research via distributed network. 100% step-down subsidiary of Reliance Industries Limited.
Digital care pathway pairs WHO-recommended HPV DNA testing with outreach, navigation and follow-up to reduce loss-to-follow-up and reach underserved districts.
